Established as a partnership in global health, the Global Fund works closely with a wide diversity of partners –implementing governments, donors, civil society, international development organizations, the private sector and communities living with and affected by the diseases. This partnership model actively supports country-owned approaches that develop and implement effective, evidence-based programs to respond to AIDS, tuberculosis and malaria.
Geneva, Switzerland, 14 - 15 November 2012
The Board of Directors of the Global Fund decided on three main issues at its 28th Meeting. The Board selected Mark Dybul as new Executive Director, as part of a broad transformation process to implement a strategy of investing for impact. The Board also approved the elements of a new funding model and decided to launch a transition to the new model immediately. The Board also approved to integrate the Affordable Medicines Facility - malaria (AMFm) into core Global Fund grant management and financial processes, following an orderly transition period in 2013. The decision was reached after extensive consultations with implementers, technical partners and donors about lessons learned from a pilot phase of AMFm.
Global Fund Appoints Mark Dybul as Executive Director (15 November 2012)
Global Fund Board Decides on Transition to New Approach for Funding Grants (15 November 2012)
Board Approves Integration of AMFm into Core Global Fund Grant Processes (15 November 2012)
Global Fund Terminates the Employment of Inspector General (15 November 2012)
Contact | Report Fraud and Abuse | Legal | RSS | Sitemap
© 2014 The Global Fund to Fight AIDS, Tuberculosis and Malaria